Lipid lowering therapy and the unmet targets in Indian patients with angiographically proven coronary artery disease: results from the OLS registry

Back

ESC Premium Access

Lipid lowering therapy and the unmet targets in Indian patients with angiographically proven coronary artery disease: results from the OLS registry

Session: Lipids as risk factors for cardiovascular disease

Topic: Drug therapy

Speaker: Doctor K. Mahajan (Himachal Pradesh, IN)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Kunal Mahajan

Himachal Heart Institute, Himachal Pradesh (India)

0 follower

8 more presentations in this session

Physician disagreement with treatment guidelines as a critical barrier to achieving low-density lipoprotein cholesterol targets in very high-risk patients: an implementation science study

Speaker: Associate Professor K. Cho (Gwangju, KR)

Lipoprotein(a) and atherosclerotic cardiovascular disease in a Brazilian tertiary hospital population

Speaker: Doctor V. Zorzanelli Rocha (Sao Paulo, BR)

Impact of glucose metabolism status on the relationship between remnant cholesterol and ischemic risk after percutaneous coronary intervention: a large-scale long-term cohort study from real-world

Speaker: Doctor K. Yan (Beijing, CN)

Association between lipoprotein particle concentration and size and progression of coronary plaque: the MACS Longitudinal Coronary CT angiography study

Speaker: Doctor R. Quispe (Baltimore, US)

The association of inflammation, triglycerides and lipoprotein(a) with cardiovascular events in the UK Biobank

Speaker: Doctor B. Tucker (Sydney, AU)

Access the full session

Lipids as risk factors for cardiovascular disease

Speakers: Doctor K. Mahajan, Associate Professor K. Cho, Doctor V. Zorzanelli Rocha, Doctor K. Yan, Doctor R. Quispe...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources